Nasal rinsing with an atomized spray improves mucociliary clearance and clinical symptoms during peak grass pollen

Abstract

Insights

Nasal rinsing with a buffered hypertonic solution significantly reduced allergic rhinitis symptoms and antihistamine use by improving mucociliary clearance (MCC). This treatment maintained nasal function, decreasing pollen contact time and allergen elution.

Area of Science:

  • Allergy and Immunology
  • Rhinology
  • Respiratory Medicine

Background:

  • Allergic rhinitis is often treated with nasal rinsing.
  • Nasal function is assessed by mucociliary clearance (MCC) and pH stability.
  • MCC influences allergen contact time and elution on the nasal mucosa.

Purpose of the Study:

  • To investigate if nasal rinsing improves allergic rhinitis by enhancing MCC.
  • To test the hypothesis that reduced pollen contact time reduces symptom severity.

Main Methods:

  • Forty patients with grass pollen allergic rhinitis were randomized into active (nasal rinsing) and control groups.
  • The active group received daily hypertonic saline rinses buffered to pH 6.1.
  • Symptoms and antihistamine use were monitored during the pollen season.

Main Results:

  • The active group showed significant reductions in nasal symptoms (p=0.01) and antihistamine use (p=0.035).
  • Mucociliary clearance (MCC) worsened significantly only in the control group (p=0.011).
  • Nasal treatment maintained MCC efficiency.

Conclusions:

  • Nasal rinsing with buffered hypertonic solution effectively reduced allergic rhinitis symptoms and medication needs.
  • The treatment preserved MCC, reducing pollen-nasal mucosa contact time and allergen elution.
  • Improved MCC is a key mechanism for nasal rinsing efficacy in allergic rhinitis.

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
810
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.4K
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
929
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K
Upper Respiratory Drugs: Decongestants01:27

Upper Respiratory Drugs: Decongestants

Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
1.1K